Exosome Diagnostics Discovers World’s First Kidney Transplant Rejection Signature from a Simple Urine Test
Pieris Completes Dosing of Healthy Volunteers in Phase I Clinical Trial for Anticalin Program in Anemia
Alvopetro Announces Q3 2026 Dividend of US$0.12 Per Share and Supplementary Information on December 31, 2025 Prospective Resources
Skyharbour Partner Company Purecore Commences Data Compilation and Target Generation at The Yurchison Uranium Property
